Thus, according to several studies on human and on mouse models, CD105+CSCs, identified in RCC, might originate from transformed CD105+ bone marrow-derived MSCs [97–101] or mesenchymal/stromal cells [102], rather than from the kidney itself. This evidence concerns the gene ENG and renal cell carcinoma.